DENSATE

This brand name is authorized in Australia, South Africa

Active ingredients

The drug DENSATE contains one active pharmaceutical ingredient (API):

1 Alendronic acid UNII 2UY4M2U3RA - ALENDRONATE SODIUM

Alendronic acid is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation. The bone formed during treatment with alendronic acid is of normal quality. Read about Alendronic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DENSATE Tablet	Marketing Authorisation Holder	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M05BA04	Alendronic acid	M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8511Y
Country: ZA	Health Products Regulatory Authority	Identifier(s): 45/3.2/0580, 45/3.2/0581